Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - [AorTech International PLC]

10 Jul 2012 10:38

RNS Number : 3107H
George and Kim Cowie
10 July 2012
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

George and Kim Cowie

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

Barclays Stockbrokers Nominee Account

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Aortech International

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

9th July 2012

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

YES/NO NO

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary £2.50 Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

65000

1.34

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary

Sale

 

15,000

230p

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

N/A

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

N/A

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES/NO

 

 

Date of disclosure:

10th July 2012

Contact name:

George Cowie

Telephone number:

07768010300

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETGGUCGMUPPUBU
Date   Source Headline
17th Feb 20115:06 pmRNSHolding(s) in Company
17th Jan 20117:00 amRNSAorTech Enters Orthopaedic Market
20th Dec 20107:00 amRNSAorTech Announces Interim Results
13th Dec 20107:00 amRNSAortech Announces Human Use of Header Technology
27th Sep 20103:00 pmRNSResult of AGM
9th Sep 20104:49 pmRNSDirector/PDMR Shareholding
24th Aug 20107:00 amRNSAnnual Report and Accounts
2nd Aug 20107:00 amRNSAorTech Announces Year End Preliminary Results
28th Jul 20108:56 amRNSHolding(s) in Company
24th May 20107:00 amRNSAorTech Signs Licensing Agreement
19th May 20107:00 amRNSDirector/PDMR Shareholding
27th Apr 20108:00 amRNSHolding(s) in Company
12th Mar 20104:50 pmRNSDirector/PDMR Shareholding
3rd Dec 20097:00 amRNSAorTech Announces Interim Results
24th Nov 20097:00 amRNSAorTech Receives Record Polymer Order
29th Sep 20097:00 amRNSAnnual Reports and Accounts Posted to Shareholders
21st Sep 20095:06 pmRNSHolding(s) in Company
16th Sep 20095:19 pmRNSResult of AGM
16th Sep 20097:00 amRNSAorTech Signs Licensing Agreement with SynCardia
16th Sep 20097:00 amRNSAorTech AGM Statement
27th Jul 20097:00 amRNSAorTech Issued US Patent for Polymer Heart Valve
22nd Jul 20097:00 amRNSAorTech Announces Final Results
9th Jul 20095:57 pmRNSHolding in Company - correction
19th Jun 200910:53 amRNSHolding(s) in Company
17th Jun 200912:07 pmRNSHolding(s) in Company
15th Jun 20095:13 pmRNSHolding(s) in Company
15th Jun 20095:11 pmRNSHolding(s) in Company
10th Jun 20097:00 amRNSAorTech Signs Licensing Agreement
5th Jun 200912:38 pmRNSHolding(s) in Company
18th May 20097:00 amRNSAorTech Signs Licensing Agreement
5th May 20099:18 amRNSHolding(s) in Company
6th Apr 20097:00 amRNSAorTech International Director/PDMR Shareholding
29th Jan 20097:00 amRNSAorTech Expands Agreement with St. Jude Medical
17th Dec 20087:00 amRNSAorTech Announces Half Yearly Results
8th Dec 20087:00 amRNSAorTech Signs New Licensing Agreement
25th Nov 20087:00 amRNSFDA Approval Granted to Key AorTech Customer
30th Sep 200810:47 amRNSHolding(s) in Company
19th Sep 200810:24 amRNSAnnual Report and Accounts
12th Sep 200812:53 pmRNSHolding(s) in Company
8th Sep 20082:22 pmRNSHolding(s) in Company
27th Aug 20082:50 pmRNSResult of AGM
27th Aug 20087:00 amRNSAGM Statement
26th Aug 200810:00 amRNSAgreement
21st Aug 20087:00 amRNSAorTech Issued Patent for Bio
6th Aug 20087:00 amRNSHolding(s) in Company
4th Aug 20087:00 amRNSAorTech Issued Patent for Pol
28th Jul 20087:00 amRNSSuccess in Animal Trials
23rd Jul 20087:00 amRNS1st Human Use of Cardiac Cann
17th Jun 20087:00 amRNSFinal Results
17th Apr 20085:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.